Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins

Heparin, a highly sulfated polysaccharide used as an antithrombotic and anticoagulant, inhibits proliferation of several cell types. We have investigated the effect of heparin and chemically modified heparins on the growth of a cell culture of a murine mammary adenocarcinoma (M3). We found that hepa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Bertolesi, G.E
Otros Autores: De Cidre, L.L, Eiján, A.M
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1994
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 10201caa a22011057a 4500
001 PAPER-19145
003 AR-BaUEN
005 20230518205030.0
008 190411s1994 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0028033260 
024 7 |2 cas  |a heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5; Heparin, 9005-49-6 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
100 1 |a Bertolesi, G.E. 
245 1 0 |a Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins 
260 |c 1994 
270 1 0 |m Bertolesi, G.E.; Area de Investigaciones, Instituto de Oncología ‘A.H. Roffo’, Universidad de Buenos Aires, Av. San Martin 5481, Buenos Aires, 1417, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Ramon y Cajal, S., Estudios histológicos sobre los tumores epiteliales (1896) Rev Tremest Microg, 1, pp. 83-85. , Buenos Aires 1417 (Argentina) 
504 |a Fisher, E.R., Fisher, B., Role of mast-cells in tumor growth (1965) Arch Pathol, 79, pp. 185-191 
504 |a de Cidre Lauría, L., de Lustig Sacerdote, E., Mast cell kinetics during tumor growth (1990) Tumor Biol, 11, pp. 196-201 
504 |a de Cidre Lauría, L., Ekján, A.M., Bertolesi, G.E., de Lustig Sacerdote, E., Acción de los mastocitos en el implate y crecimiento tumoral (1991) Medicina (B Aires), 51, p. 411 
504 |a Casu, B., Structure and biological activity of heparin (1985) Adv Carbohydr Chem Biochem, 43, pp. 51-134 
504 |a Clowes, A.W., Karnovsky, M.J., Suppression by heparin of smooth muscle cell proliferation in injured arteries (1977) Nature, 265, pp. 625-626 
504 |a Castellot, J.J., Addonizio, M.L., Rosenberg, R.D., Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth (1981) J Cell Biol, 90, pp. 372-377 
504 |a Castellot, J.J., Hoover, R.L., Harper, P.A., Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation (1985) Am J Pathol, 120, pp. 427-435 
504 |a Paul, D., Niewiarosky, S., Varma, K.G., Inhibition of mitogenic activity of a platelet growth factor (platelet basic protein) in 3T3 cells by heparin (1980) Thromb Res, 18, pp. 883-888 
504 |a Wright, T.C., Johnstone, T.V., Castellot, J.J., Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF (1985) J Cell Physiol, 125, pp. 499-506 
504 |a Wright, T.C., Karnovsky, M.J., Metabolic effects of heparin on rat cervical epithelial cells (1987) J Cell Physiol, 132, pp. 255-262 
504 |a Ristow, H.J., Messmer, T.O., Heparin as a growth inhibitor for cultured kera-tinocytes (1988) J Cell Biol, 107, p. 269 
504 |a Halper, J., Carter, B.J., Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors (1989) J Cell Physiol, 141, pp. 16-23 
504 |a Burgess, W.H., McIag, T., The heparin-binding (fibroblast) growth factor family of proteins (1989) Ann Rev Biochem, 58, pp. 575-606 
504 |a Rifkin, D.B., Moscatelli, D., Recent developments in the cell biology of basic fibroblast growth factor (1989) J Cell Biol, 109, pp. 1-6 
504 |a Damon, D.H., Halegoua, S., D’Amore, P., Wagner, J.A., Rapid fibroblast growth factor-induced increases in protein phosphorylation and ornithine decarboxylase activity; Regulation by heparin and comparison to nerve growth factor-induced increases (1992) Exp Cell Res, 201, pp. 154-159 
504 |a Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D., Vlodavsky, I., A heparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane (1988) Am J Pathol, 130, pp. 393-399 
504 |a Saksela, O., Rifkin, D., Releaseofbasic fibroblast growth factor-heparan sulfate complexes from endothelial cells (1990) J Cell Biol, 110, pp. 767-775 
504 |a Bal de Kier Joffé, E., Puricelli, L., del Vidal, M.C., Characterization of two murine mammary adenocarcinoma tumors with different metastatic ability (1983) J Exp Clin Cancer Res, 2, pp. 151-160 
504 |a Pereyra-Alfonso, S., Haedo, A., Bal de Kier Joffé, E., Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas (1988) Int J Cancer, 42, pp. 59-63 
504 |a Bal de Kier Joffé, E., Puricelli, L., del Vidal, M.C., de Lustig, E.S., Modified adhesion behaviour after in vitro passage of two related murine mammary adenocarcinomas with different metastasizing ability (1986) Invasion Metastasis, 6, pp. 302-312 
504 |a Oyama, V., Eagle, H., Measurement of cell growth in tissue culture with phenol reagent (Folin-Ciocaltcau) (1956) Proc Soc Exp Biol Med, 91, pp. 305-307 
504 |a Labarca, C., Paigen, K., A simple, rapid and sensitive DNA assay procedure (1980) Anal Biochem, 102, pp. 344-352 
504 |a Pearse, A.G.E., (1986) Metachromatic methods for mucosubstances; in Histochemistry Theoretical and Applied, 1, pp. 330-334. , Boston, Little, Brown & Co 
504 |a Castellot, J.J., Beeler, D.L., Rosenberg, R.D., Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells (1984) J Cell Physiol, 120, pp. 315-320 
504 |a Castellot, J.J., Wong, K., Herman, B., Binding and internalization of heparin by vascular smooth muscle cells (1985) J Cell Physyol, 124, pp. 13-20 
504 |a Vlodavsky, I., Komer, G., Ishai-Michaeli, R., Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis (1990) Cancer Metastasis Rev, 9, pp. 203-226 
504 |a Rapraeger, A., Krufka, A., Olwin, B.B., Requirement of heparan sulfate for bFGF-mediated fibroblast growth factor and myoblast differentiation (1991) Science, 252, pp. 1705-1708 
504 |a Bashkin, P., Doctrow, S., Klagsbrun, M., Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by he-paritinase and heparin-like molecules (1989) Biochemistry, 28, pp. 1737-1743 
504 |a Ishaì-Michaeli, R., Svahn, C.-M., Webwe, M., Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix (1992) Biochemistry, 31, pp. 2080-2088 
504 |a Bar-Ner, M., Eldor, A., Wasserman, Y., Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anti-coagulant heparin species (1987) Blood, 70, pp. 551-557 
504 |a Coombe, D.R., Pariesh, C.R., Ramshaw, I.A., Analysis of the inhibition of tumour metastasis by sulfated polysaccharides (1987) Int J Cancer, 39, pp. 82-88 
504 |a Nakajima, M., Irimura, T., Nicolson, G.L., Heparanases and tumor metastases (1988) J Cell Biochem, 36, pp. 157-1678 
504 |a Parish, C.R., Coombe, D.R., Jakobsen, K.B., Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases (1987) Int J Cancer, 40, pp. 511-517 
520 3 |a Heparin, a highly sulfated polysaccharide used as an antithrombotic and anticoagulant, inhibits proliferation of several cell types. We have investigated the effect of heparin and chemically modified heparins on the growth of a cell culture of a murine mammary adenocarcinoma (M3). We found that heparin inhibited the proliferation of M3 cells growing either with or without 2% fetal calf serum (FCS) in a dose-dependent and reversible fashion. Several heparins with different anticoagulant properties showed a similar antiproliferative effect. Histological assays showed that heparin was internalized and appeared in cytoplasmic vesicules. O-desulfated. O/N-desul- fated N-acetylated and N-desulfated heparins lost their antiproliferative activity, while N-desulfated N-acetylated heparin significantly inhibited cell proliferation with or without FCS. The finding of an antiproliferative action of N-desulfated N-acetylated heparin which does not show anticoagulant activity suggests a possible therapeutic role for this compound as an antineoplastic drug. © 1994 S. Karger AG, Basel.  |l eng 
593 |a Area de Investigaciones, Institute de Oncología ‘A.H. Roffo’, Universidad de Buenos Aires, Buenos Aires, Argentina 
593 |a Laboratorio de Histología Animal, Departamento de Biología, Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina 
690 1 0 |a GROWTH 
690 1 0 |a HEPARIN 
690 1 0 |a HEPARINOID 
690 1 0 |a INHIBITION 
690 1 0 |a METASTASIS 
690 1 0 |a MURINE ADENOCARCINOMA 
690 1 0 |a HEPARIN 
690 1 0 |a HEPARIN DERIVATIVE 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ARTICLE 
690 1 0 |a BREAST CARCINOMA 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a GROWTH INHIBITION 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a ADENOCARCINOMA 
690 1 0 |a ANIMAL 
690 1 0 |a CELL DIVISION 
690 1 0 |a COMPARATIVE STUDY 
690 1 0 |a CYTOPLASMIC GRANULES 
690 1 0 |a HEPARIN 
690 1 0 |a KINETICS 
690 1 0 |a MAMMARY NEOPLASMS, EXPERIMENTAL 
690 1 0 |a MICE 
690 1 0 |a MICE, INBRED BALB C 
690 1 0 |a SUPPORT, NON-U.S. GOV'T 
690 1 0 |a TIME FACTORS 
690 1 0 |a TUMOR CELLS, CULTURED 
700 1 |a De Cidre, L.L. 
700 1 |a Eiján, A.M. 
773 0 |d 1994  |g v. 15  |h pp. 275-283  |k n. 5  |p Tumor Biol.  |x 10104283  |t Tumor Biology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028033260&doi=10.1159%2f000217902&partnerID=40&md5=fb6def87eeb9e3073dcd0b12bd5b35d5  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1159/000217902  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_10104283_v15_n5_p275_Bertolesi  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10104283_v15_n5_p275_Bertolesi  |y Registro en la Biblioteca Digital 
961 |a paper_10104283_v15_n5_p275_Bertolesi  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 80098